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Immunomediated and Ischemia-Independent Inflammation
of Coronary Microvessels in Unstable Angina
Gian Gastone Neri Serneri, Maria Boddi, Pietro Amedeo Modesti, Ilaria Cecioni, Mirella Coppo,
Maria Letizia Papa, Thomas Toscano, Antonio Marullo, Mario Chiavarelli
Abstract—This study investigated whether the myocardium is involved in the acute inflammatory reaction associated with
bursts of unstable angina (UA). We looked for the presence of activated DR inflammatory cells and the expression
patterns, localization, and immunostaining identification of genes for cytokines (IL-1, TNF-, IL-6, and IFN-),
MCP-1, and iNOS in the left ventricle biopsies from 2-vessel disease anginal patients, 24 with UA and 12 with stable
angina (SA), who underwent coronary bypass surgery. Biopsy specimens from 6 patients with mitral stenosis who
underwent valve replacement were examined as control hearts (CHs). Plasma levels of IL-2 soluble receptor (sIL-2R)
were measured as a marker of systemic immune reaction. In CHs, DR cells were undetectable, and cytokine and iNOS
mRNA expression were negligible. UA patients had higher sIL-2R levels than SA patients (P0.01), and their biopsy
specimens showed both numerous DR cells identified as lymphocytes, macrophages, endothelial cells, and elevated
expression levels of cytokine and iNOS genes (from 2.4- to 6.1-fold vs SA; P0.01). Cytokine and iNOS genes and
proteins were localized in endothelial cells without involvement of myocytes. IL-1 and MCP-1 mRNAs were nearly
undetectable. No significant differences were found in the number of DR cells, levels of cytokine, and iNOS genes
between potentially ischemic and nonischemic left ventricle areas. In SA specimens, DR cells were very rare and only
mRNAs for TNF- and iNOS genes were overexpressed versus CHs. These results indicated that an acute
immunomediated inflammatory reaction, essentially involving coronary microvessels, is demonstrable in UA patients.
(Circ Res. 2003;92:1359-1366.)
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Patients with unstable angina (UA) class IIB and IIIB ofBraunwald’s classification have ischemia at rest or at
very low workloads. The common cause of the transient
reduction of coronary flow is considered to be a nonocclusive
thrombus on a fissured or eroded atherosclerotic plaque that
typically had caused only mild-to-moderate obstruction pre-
viously.1 However, recent angioscopic studies performed on
UA patients classified according to Braunwald’s classifica-
tion have shown that intracoronary thrombi are detectable
only in a proportion of patients, ranging from 39% to 68%,2–6
and are more frequently found in patients with refractory
angina. Because the sensitivity of percutaneous coronary
angioscopy for detecting coronary lesions has been found to
be superior to that of coronary angiography,7 it is reasonable
to suppose that intracoronary thrombi remain undetected in at
least 30% of class IIB and IIIB UA patients. Vasoconstriction
at both the site of stenosis or thrombus and at the microvas-
cular level may play a contributory role in reducing coronary
blood flow.1 In atherosclerosis a reduced endothelium-
dependent relaxation has been demonstrated both at the level
of epicardial coronary arteries8,9 and coronary microvessels.10
In UA, a coronary microvessel dysfunction may also be
facilitated by the intermittent ischemia that in experimental
and human studies has been found to elicit an accelerated
inflammatory response by cardiac tissues.11,12 Several func-
tional studies have described a reduced capacity for vasodi-
lation of small coronary vessels in anginal patients13 and an
improper regulation of coronary microcirculation to the
enhanced oxygen demand.14,15 A recent study has shown that
the expression levels of both heat shock protein 72 and
endothelial nitric oxide synthase are higher in biopsy speci-
mens from the right atrium of UA patients than of patients
with stable angina (SA),16 raising the possibility that the
myocardium may be involved in UA. However, no informa-
tion is available on whether the myocardium and coronary
microvessels are involved in the inflammatory reaction asso-
ciated with UA. Therefore, we planned the present study with
the following objectives: (1) to investigate whether the
myocardium is involved in UA, and if so, (2) to identify the
cellular and molecular features of the myocardial inflamma-
tion and (3) to examine the mechanism(s) responsible for
myocardium involvement.
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Materials and Methods
Study Population
Twenty-four patients with UA in class IIB (n10) and IIIB (n14)
of Braunwald’s classification and 12 with SA in Canadian Class II
(n7) and III (n5) were investigated. Patients with UA and SA
were considered for inclusion in the study if they had a 2-vessel
disease, one of which was the left anterior descendent (LAD) artery,
and they had been scheduled for a coronary artery bypass graft
(CABG) because unsuitable for percutaneous transluminal angio-
plasty. More precisely, 7 patients had disease of the LAD and
circumflex artery (LCx), 2 of the LAD and obtuse marginal artery
(OMA), and 15 patients of the LAD and coronary right artery (CRA).
The distribution of coronary vessel disease and baseline clinical
characteristics of the study population are reported in the Table.
Diagnosis and risk evaluation of UA and SA patients were performed
according to the ACC/AHA guidelines.17,18 High-risk patients and
patients with recent (ie, within the preceding 3 months) myocardial
infarction were not accepted for the study. Only patients with recent
onset (7 days before admission) of angina who had at least 2
episodes of angina at rest or 1 episode lasting more than 20 minutes
during the preceding 24 hours associated with transient ischemic
ST-segment changes and troponin T levels 0.1 ng/mL (troponin
T–negative) were included in the study. UA patients received aspirin
(100 mg/d) and nitrates. In addition to this therapy, 15 patients were
on -blockers, 17 were treated with heparin, and 8 with calcium-an-
tagonists. Anginal episodes were recorded up to surgery. Patients
with SA were on aspirin (100 mg/d) and nitrates. Patients who on
admission had had recent infectious diseases, known or suspected
neoplasms, erythrocyte sedimentation rate 20 mm/h were not
considered eligible for the study. The protocol of this study complies
with the principles of the Helsinki declaration and was approved by
the Ethical Committee of our Institution. All patients gave their
informed consent to participate and to have blood samples and
biopsy specimens used for the study.
Experimental Procedures
Patients with the above mentioned clinical characteristics were
enrolled in the study after coronary angiography, which was per-
formed from 48 to 96 hours after admission. Severity of coronary
lesions and presence and grade of coronary collateral circulation
were evaluated. No patients had ongoing anginal symptoms when
undergoing surgery. CABG was performed from 6 to 9 days after
coronary angiography. On the day preceding surgery, 10 mL of
venous blood was withdrawn from UA and SA patients as well as
from 15 healthy controls to measure serum concentration of sIL-2R,
a long-lasting marker of lymphocyte activation.19 Immediately after
sternotomy and before inducing cardioplegia, 2 transmural biopsies
(100.5 mm) were taken from the anterolateral wall of the left
ventricle close to the apex in the distribution territory of the LAD
artery through a biopsy needle (MN1416, diameter 2.1 mm; BIP
Gembh). Because this area was potentially ischemic in all the
patients, in 9 of the 15 with coronary disease involving the LAD and
CRA, an additional biopsy was taken from the free left ventricle wall
in an area which appeared normally perfused at 211Thallium scintig-
raphy performed before coronary angiography and was supplied by
obtuse marginal branches angiographically free from atherosclerotic
lesions. The surgeon did not take the biopsy specimens if the area
selected for biopsies appeared as a site of an old infarction. The
amount of tissue obtained was sufficient to allow quantification and
localization of mRNAs and immunohistochemistry studies of the
corresponding proteins for each patient. Cardiac specimens were also
obtained from the anterolateral wall of the left ventricle of 6 patients
with mitral stenosis who underwent surgical valve replacement
(control hearts, CHs). Handling of biopsy specimens for RT-PCR,
hybridization in situ, and immunohistochemical studies were per-
formed as previously described20 (see expanded Materials and
Methods section presented in the online data supplement available at
http://www.circresaha.org).
Immunohistochemical Detection of Inflammatory
Cells and Morphometric Analysis
The presence and identification of activated inflammatory cells in the
myocardium were determined by immunohistochemical analysis for
major histocompatibility class II molecules (HLA-DR) on adjacent
serial sections stained for macrophages, T lymphocytes, and endo-
thelial cells using human monoclonal antibodies (see detailed list in
expanded Materials and Methods). The presence of neutrophils was
also investigated by immunostaining for elastase. Immunostains
were visualized through the avidin-biotin horseradish peroxidase
visualization system (Vector Laboratories). The number of DR
inflammatory (lymphocytes and macrophages) and endothelial cells
was expressed as cells/mm2. Collagen staining was expressed as the
percentage of Picrosirius red area to the total area of the biopsied
sample.12 The quantitative analysis was performed by means of Zeiss
Image Software. The entire stained biopsied sample was scanned
with Adobe Photoshop software (Adobe Systems) and a Leaf
Microluminal digital camera.
RT-PCR Quantification of mRNA for Cytokines,
MCP-1, and iNOS and In Situ
Hybridization Studies
mRNAs for interleukin (IL)-1, tumor necrosis factor- (TNF-),
IL-6, interferon- (IFN-), monocyte chemoattractant protein-1
(MCP-1), and inducible nitric oxide (iNOS) were quantified by
RT-PCR, as previously reported,20 by means of specific primers and
expressed as ratios to the constitutively expressed gene for glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) as described else-
where.21 Characteristics of primers and operative conditions for
RT-PCR are reported in the expanded Material and Methods. The in
situ hybridization procedure was performed with specific cDNA
photobiotin-labeled (Vector) probes.20,21 The localization of cyto-
kine and iNOS genes was done on serial sections adjacent to those
immunostained for macrophages, T lymphocytes, and endothelial
cells (see online data supplement).
Immunohistochemical Analysis for Cytokines and
iNOS Proteins
Cytokine proteins were assayed by immunohistochemical analysis
according to the avidin-biotin peroxidase method using primary
monoclonal antibodies against human TNF- (Santa Cruz Biotech-
Characteristics of Controls and Anginal Patients
Characteristics
Controls
(n15)
Stable
Angina
(n12)
Unstable
Angina
(n24)
Males/Females 11/4 10/2 18/6
Age, y 5412 627 5912
Weight, kg 77.57.2 78.57.4 75.38.4
Smoking, % 9 (60) 8 (67) 17 (70)
Cholesterolemia, mmol/L 4.30.9 5.30.7 5.40.5
Diabetes, % 2 (16) 3 (25)* 6 (25)*
Hypertension, % 6 (40) 5 (42) 11 (46)
Left ventricular mass, g/m2 11214 11112 11314
LVEF, % 60.45.2 53.64.5 54.95.1
Mean aortic pressure, mm Hg 95.111.9 98.212.6 100.712.6
Mean angiographic score†    15.84.3 16.24.2
Coronary blood flow, mL/min 85.18.4 80.64.5 82.613.8
CVR, mm Hg/mL per min 1.260.34 1.520.49 1.580.53
LVEF indicates left ventricular ejection fraction; CVR, coronary vascular
resistance. Values are meanSD or number (percentage).
*P0.01 vs controls.
†According to the American Heart Association.
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nology), IL-6 (RD System), IFN- (Sigma), and iNOS (Transduction
Laboratory).
Statistical Analysis
Data are expressed as meanSD. Serum concentrations (median
values) of sIL-2R are given as medians and range. Groups were
compared by Student’s t test for paired and unpaired data. We used
one-way analysis of variance (ANOVA), followed by Tukey’s
multiple-range comparison test, when appropriate, to analyze the
differences among the 3 groups. For sIL-2R, we applied Kruskal-
Wallis’s nonparametric test for one-way ANOVA (H test), followed
by the post hoc test to examine the differences among the 3 groups.
We used linear regression analysis to test the relationships between
severity of angina and (1) serum sIL-2R concentration and (2) the
expression levels of cytokine and iNOS genes. We also obtained
correlations between the severity of coronary lesions and each of
these variables. Statistical significance was taken as P0.05. We
used BMDP statistical software (BMDP Statistical Software Inc) for
all calculations.
Results
Clinical Course
No patients had heart failure, myocardial infarction, or died
before, during, or after the surgical procedure. Nine out of 24
UA patients and 2 out of 12 SA patients suffered anginal
episodes in the interval between enrollment and surgery:
more precisely, 1 patient had 1 episode, 5 had 2 episodes, and
3 patients had from 3 to 5 episodes. No anginal episode lasted
more than 5 to 6 minutes and only 2 patients had angina in the
2 days before surgery.
Serum concentrations (median values) of sIL-2R were
significantly (P0.001) higher in UA (147 pmol/L, range 93
to 212.5) than in SA patients (91 pmol/L, range 73.2 to 117.2)
and controls (83 pmol/L, range 71 to 112.7). Twenty-two out
of 24 UA patients (87%) and 1 of 12 SA patients had sIL-2R
values above the confidence limits of controls. No relation-
ship was found between serum levels of sIL-2R and either the
severity of angiographic coronary lesions or the severity of
angina in terms of number and duration of the anginal
episodes (r0.12, P0.73; r0.16, P0.71; and r0.15,
P0.68; respectively).
Collateral blood flow was angiographically demonstrable
in only 7 patients (grade 0 to 3) and in 4 patients supplied the
area of ventricular wall from which biopsy specimens were
taken. The expression levels of cytokine and iNOS genes did
not differ between these patients and those without collateral
blood flow.
Inflammatory Cells in Myocardium
and Morphometry
Biopsy specimens from UA patients showed numerous cells
expressing DR molecules, which, conversely, were very rare
in SA patients and absent in CHs (Figure 1). In adjacent serial
sections, the great majority of DR cells was represented by
endothelial cells identified by both CD31 and von Willebrand
immunostaining, and the remaining DR cells were identified
as CD68 (macrophages) or CD3 (lymphocytes) (Figure 2).
DR lymphocytes and macrophages were exclusively local-
ized in myocardial interstitium. The quantitative distribution
of the DR cells in the biopsies from UA, SA, and CHs and
in potentially ischemic and nonischemic left ventricular areas
is reported in Figure 3. No elastase positive cells (neutrophil
leukocytes) were detectable in any of the biopsies. Collagen
content was less than 3% in UA biopsies, whereas it ranged
between 4.3% and 8.6% in SA biopsies.
Expression Levels of Cytokine, MCP-1, and
iNOS mRNAs
RT-PCR showed that the expression levels of mRNAs were
negligible or undetectable in biopsy specimens from CHs
(Figure 4). In SA biopsies, mRNAs for IL-1, IL-6, IFN-,
and MCP-1 were undetectable or negligible, whereas only
TNF- and iNOS genes were clearly detectable and ex-
pressed at a higher level than in CHs (P0.05 and 0.01,
respectively) (Figure 4). By contrast, in UA biopsies the
genes for TNF-, IL-6, IFN-, and iNOS were overex-
pressed, from 2.4-fold for TNF- (P0.001) to 6.1-fold for
IL-6 (P0.001) when compared with SA hearts (Figure 4).
IL-1 and MCP-1 gene expression was undetectable or
negligible. In patients with LAD plus CRA disease, the
expression levels of mRNAs for cytokines and iNOS were
not significantly different for potentially ischemic and nonis-
chemic areas (Figure 4).
Correlation Between Severity of Microvessel
Inflammation and Clinical and Systemic Variables
The degree of the microvessel inflammatory response com-
puted for each patient as the sum of expression levels of
TNF-, IL-6, IFN-, and iNOS genes was not correlated with
Figure 1. Immunostaining for cells expressing DR antigens in
myocardial biopsies. Positive signal revealed by red-brown
staining. DR cells are undetectable in CHs (A) and very few in
SA specimens (B), whereas numerous DR cells are present in
UA biopsy specimens (C and D) without significant differences
between ischemic (E) and nonischemic areas (F). A, B, C, E, and
F, magnification 100; D, magnification 400. Signal was
revealed by avidin-biotin peroxidase system. Arrows indicate
DR cells in B.
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either the severity of coronary lesions (r0.19, P0.85) or
the severity of angina defined as number or as duration of
anginal episodes (r0.20, P0.87 and r0.21, P0.89,
respectively). Conversely, the degree of the myocardial in-
flammatory response was positively correlated with plasma
levels of sIL-2R (r0.43, P0.05).
Localization of Cytokine and iNOS mRNAs
Negative and positive controls for in situ hybridization
showed that the signal was specific for mRNA, and that
mRNA in the biopsies was intact. In CHs, mRNAs for
cytokines and iNOS were undetectable. In SA hearts, gene
signals for IFN- and IL-6 genes were undetectable, whereas
signals for TNF- and iNOS mRNAs were weakly expressed
(Figure 5). Conversely, in UA biopsy specimens, the genes
for all the cytokines examined and iNOS were detectable
(Figure 5) both in potentially ischemic and nonischemic areas
(online Figure 1 in the online data supplement available at
http://www.circresaha.org). TNF-, IL-6, and iNOS genes
were mainly expressed on endothelial cells and more weakly
on interstitial cells. The IFN- gene was detectable both in
endothelial cells and lymphocytes, whereas TNF-, IL-6, and
iNOS genes were also expressed on macrophages (Figure 6).
Cardiomyocytes did not express mRNA either for cytokines
or iNOS (Figure 6).
Immunohistochemical Localization of Cytokine
and iNOS Proteins
We did not find immunoreactivity for cytokine and iNOS
proteins in CHs, and only weak signals for TNF- and iNOS
proteins in SA biopsies (Figure 7). Conversely, in UA hearts,
immunoreactivity for TNF-, IL-6, IFN-, and iNOS proteins
was highly expressed and predominantly localized in micro-
vascular endothelial cells, in lymphocytes and macrophages
but not in cardiomyocytes (Figure 7).
Discussion
Our results showed that an acute inflammatory process
involving coronary microvessels, but not cardiomyocytes, is
detectable in UA patients. The microvessel inflammation is
revealed by the presence of inflammatory (lymphocytes and
macrophages) and resident cells, particularly endothelial
cells, expressing HLA-DR molecules, as well as the increased
mRNA levels for several cytokines (TNF-, IL-6, and IFN-)
and iNOS in the left ventricle biopsies from UA. Although
RT-PCR allows only a semiquantitative assay, the marked
Figure 2. Immunohistochemical staining for HLA-DR cells (A),
CD31 (B), and von Willebrand (C and D) endothelial cells,
CD3 T lymphocytes (E and F), and CD68 macrophages (G
and H) in adjacent serial sections of myocardial biopsies from
UA patients. Positive signal revealed by red-brown staining (A,
B, C, E, and G, magnification 200; D, F, and H, magnification
1000). Arrows indicate lymphocytes in E and F and macro-
phages in G and H.
Figure 3. A, Bar graphs show mean numberSD of all DR
cells in control hearts (CHs), SA, and UA hearts. Bar graphs
show mean numberSD of all DR cells, T lymphocytes (CD3),
macrophages (CD68), and endothelial cells (CD31) in biopsies
from SA hearts (B) and UA hearts examined in potentially ische-
mic (C) and nonischemic (D) myocardial areas.
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differences in the expression levels (from 2.4- to 6.1-fold) of
cytokine and iNOS genes between UA and SA patients and
even more versus CHs by far overcome the limits of the
method and corroborate the existence of an inflammatory
process. In situ hybridization studies of cytokine and iNOS
genes and immunostaining of their proteins revealed that the
inflammatory process was essentially confined to endothelial
cells and, to a lesser extent, to interstitial cells.
Because myocardial ischemia or necrosis may induce an
acute inflammatory reaction, it is crucial to analyze the
meaning of the inflammatory process found in UA patients.
According to our enrollment criteria, UA patients were
troponin-negative, and myocardial biopsies were taken before
extracorporeal circulation, so the inflammatory process can-
not be considered a reaction to myocardial necrosis22 or
surgery.23 Myocardial inflammatory reaction may also be
induced by an acute ischemic episode followed by reperfu-
sion according to the classic ischemia/reperfusion injury.24 In
this situation, polymorphonuclear leukocytes, mainly neutro-
phil leukocytes, are recruited.24 Immunostaining of myocar-
dial biopsies from our patients did not show elastase, the
marker of neutrophils recruitment. A recent study reported
that neutrophils undergo activation during the passage across
the coronary vascular bed in UA patients.25 Myocardial
ischemia alone did not suffice to induce the inflammatory
state of the coronary bed in UA patients, because in the same
study, neutrophils were not activated in patients who had
multiple episodes of variant angina.25 In our UA patients,
intermittent ischemia could have induced myocardial inflam-
matory process like that observed in the late phase of
ischemic preconditioning11 or hibernating myocardium.26 In
UA patients with LAD and CRA disease and insignificant
lesions of the LCx artery, the number of DR cells and the
expression levels of cytokines and iNOS genes were not
different between the potentially ischemic and nonischemic
areas, that is, areas normally perfused at 211thallium scintig-
raphy. Moreover, several specific histological and molecular
features differentiate coronary microvessel inflammation
found in UA patients from the hibernating myocardium and
the late phase of ischemic preconditioning. Hibernating
myocardium is associated with degeneration of cardiomyo-
cytes, loss of contractile material27 fibrosis and MCP-1 gene
overexpression.12 By contrast, all these findings were not
observable in the UA coronary microvessel inflammation. In
the late phase of preconditioning, IL-1 and TNF- genes are
coexpressed28 and the iNOS gene is selectively upregulated in
the myocytes, but not in the small vessels and fibroblasts.11,29
In UA inflammation, instead, IL-1 was not expressed and
iNOS mRNA was upregulated in the microvessels but not in
the myocytes, thus indicating that myocytes were not in-
volved in the coronary microvessel inflammation. C-reactive
protein (CRP) at 5 g/mL exerts a direct inflammatory effect
on both cultured human umbilical vein and coronary artery
endothelial cells.30 Because we did not know the CRP
intracoronary levels of our patients, we cannot rule out that
CRP contributed to the endothelial inflammatory process.
However, the high number of DR endothelial cells strongly
suggests an immunological activation31 independently of any
Figure 4. A, RT-PCR expression of
mRNAs for GAPDH, TNF-, IL-6, IFN-,
iNOS, MCP-1, and lack of IL-1 gene
expression in biopsy specimens from
control, SA, and UA hearts. Cytokine and
iNOS mRNA levels in potentially ischemic
and nonischemic areas of UA hearts are
separately shown on the right (PIA,
potentially nonischemic areas; NIA, non-
ischemic areas).The positive control for
IL-1 was obtained using human lym-
phocytes. Representative experiments
are shown. B, Bar graphs show densito-
metric quantification of RT-PCR products
of cytokines and iNOS obtained in con-
trol, SA, and UA hearts. C, Densitometric
quantification of RT-PCR products of cy-
tokines and iNOS in potentially ischemic
and nonischemic areas of the same UA
patients. Data are presented as
meanSD. *P0.01 vs control and
#P0.01 vs SA specimens.
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possible inflammatory action by CRP. The different histolog-
ical and molecular characteristics of the coronary microvessel
inflammation observed in our patients and the ischemia-
related inflammatory reactions, as well as the lack of signif-
icant differences in the expression levels of inflammatory
cytokine and iNOS genes between the nonischemic and
potentially ischemic myocardial areas, make it highly un-
likely that the coronary microvessel inflammation is a direct
consequence of intermittent ischemia. We cannot exclude,
however, that the microvessel inflammation may be an
indirect consequence of transiently increased sympathetic
activity32 or an ischemia-related stress response and, there-
fore, a process extending beyond the directly ischemic region.
Nor can we rule out that subclinical showers of microemboli
or active material released by multiple active plaques33 might
have reached the myocardial areas not subjected to ischemia.
Immune Reaction
The major distinctive feature of coronary microvessel inflam-
mation was the expression of HLA-DR molecules on the
inflammatory cells (T cells and macrophages) and endothelial
cells. Expression of DR molecules provides evidence that
antigen presentation occurred and an immunological reaction
is ongoing or has recently happened.34 This contention is
strengthened by the expression of IFN- gene and protein
both in lymphocytes and endothelial cells and by the simul-
taneous increase in sIL-2R in serum, a marker of recent T-cell
activation.19 The expression of the IFN- gene and protein
together with DR molecules on the endothelial cells indicates
Figure 6. In situ hybridization for TNF- (A), IL-6 (C), IFN- (E),
and iNOS (G) and their localization in different cellular types in
myocardial biopsies from nonischemic areas of UA patients.
Serial adjacent sections were immunostained for macrophages
(CD68) (B and D), T lymphocytes (CD3) (F), and endothelial
cells (CD31) (H) for the localization of cytokine and iNOS genes
on different cell types. A, C, E, and G, magnification 400; B, D,
F, and H, magnification 1000. Arrows indicate macrophages in
A, B, C, and D, lymphocytes in E and F, and endothelial cells in
G and H.
Figure 5. In situ hybridization for TNF- (A and B), IL-6 (C and
D), IFN- (E and F), iNOS (G and H), GAPDH (I), and plasmid
vector pBR322 (L) in left ventricular biopsies from SA (A, C, E,
and G) and UA specimens (B, D, F, and H). Positive mRNA sig-
nal was revealed by red-brown staining. In SA hearts, positive
mRNA signal was almost absent, whereas in UA hearts, mRNAs
for cytokines and iNOS were expressed in interstitial and, espe-
cially, in endothelial cells. Cardiomyocytes did not express
mRNA either for cytokines or iNOS. Magnification 400.
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the participation of the microvascular endothelium in the
immune reaction.35 These findings are consistent with histo-
logical data pointing to the occurrence of a recent immune
activation within the culprit plaques of UA patients. These
plaques are characterized by a markedly higher number of T
cells, macrophages, and smooth muscle cells expressing DR
molecules than that found in SA patients.36–38 Moreover, T
cells of culprit plaques express IL-2R on their membrane,37
suggesting a recent immune activation.39 Human and exper-
imental studies have shown that antigens are formed into the
plaques during LDL oxidation or degradation.40 T-cell clones
from human atherosclerotic plaques respond to oxidized LDL
by proliferation and IFN- secretion,41 and circulating T cells
from UA patients, but not from SA patients or normal control
subjects, proliferate in vitro in response to oxidized LDL
and/or to autologous proteins obtained from coronary culprit
lesions.42
Microvessel Inflammation and Angina
We found a diffuse inflammatory process with major distinc-
tive features of immune reactions in UA patients. Patients
were on full medical therapy, and the interval between their
admission and obtaining biopsies (from 9 to 20 days) did not
permit us to investigate the relationship between the mi-
crovessel inflammation and the clinical data. Only 37% of the
patients experienced few, moderate anginal episodes during
the study period. Thus, the clinical significance of the
microvessel inflammation remains to be defined. It appears
reasonable to suppose that a widespread coronary microves-
sel inflammation might contribute to the paradoxical increase
in the microvessel resistance during ischemia in UA pa-
tients15 or to the alterations in coronary flow in myocardial
territory perfused by arteries without stenosis or culprit
lesions in patients with UA or recent infarction.13,43 However,
we are aware that further studies are needed to explore the
significance of the microvessel inflammation. Conversely,
the results of the present study have a pathophysiological
meaning because they indicate that in UA the inflammation is
not confined to the culprit unstable plaque but involves
coronary microvessels as well. Our results are consistent with
recent angiographic, angioscopic, and intracoronary ultra-
sound studies that show that, in addition to the responsible
lesion, patients with UA or myocardial infarction may harbor
multiple plaques, eroded and thrombosed, or with the char-
acteristics of the vulnerable plaques diffused on the 3 coro-
nary arteries.44–46 Finally, the distinctive features of immu-
nomediated inflammation both in unstable plaques and
coronary microvessels suggest that immune factors may play
a role in precipitating the acute activation of the chronic
smoldering inflammatory process of coronary atherosclerosis.
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Expanded materials and methods section
Transmural left ventricle biopsies and tissue processing
Immediately after sternotomy and before inducing cardioplegia, transmural biopsies (10 x
0.5 mm) were taken through a biopsie needle (MN1416 diameter 2.1 mm; BIP Gembh).
One of the biopsies was collected in sterile RNAase-free tubes immediately frozen in liquid
nitrogen in the operating theater and thereafter transferred to -80°C for storage. The other
one was used for immunohistochemical studies. This sample was immediately immersed
in buffered 10% formalin for 18 hours, dehydrated in an alcohol series (50%, 75%, 95%
ethanol and absolute) and, then, in xylene and finally embedded in a paraffin block.
Immunohistochemistry
Paraffin blocks obtained from bioptic specimens were serially cut into sequential 3-5 µm
sections by microtomy. At least 25 serial adjacent sections from 1 biopsy from each patient
were mounted for immunohistochemistry and stained at 3 cutting levels with hematoxylin
and eosin for morphologic evaluation. Serial sections were deparaffinized with xylene (3
times for 5 min) and immediately treated with 3% hydrogen peroxide (10 min) to block
endogenous peroxidase. After washing in phosphate buffered saline (PBS) (3 times for 5
min), non specific binding was blocked with normal blocking serum and then the sections
were incubated overnight at 4°C with the primary antibody. All antibodies were diluted in
PBS containing 10% normal blocking serum. After washing (3 times for 10 min) with PBS,
the sections were incubated at room temperature for 1 hour with biotinylated secondary
antibody. After an extensive wash with PBS (3 times for 10 min), antibody binding was
revealed with the avidin-biotin peroxidase complex technique (Vector Laboratories) and 3-
amino-9-ethylcarbazole was used as the chromogenic substrate. Cells nuclei were
counterstained with hematoxylin. Negative controls were obtained by omitting the primary
antibody.
Immunohistochemical detection of inflammatory cells
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2The presence and identification of activated inflammatory cells in the myocardium were
determined by immunostaining for major histocompatibility class II antigen (HLA-DR) on
sections adjacent to serial sections stained for macrophages, T lymphocytes and
endothelial cells. The presence of neutrophils was also investigated by immunostaining for
elastase.
The following primary antibodies were used: mouse monoclonal antibody anti human HLA-
DR (Dako, 1:50 dilution), mouse monoclonal antibody anti macrophages CD68 (Dako,
1:50 dilution), mouse monoclonal antibody anti T lymphocytes CD3 (Santa Cruz
Biotechnology, 1:30 dilution), mouse monoclonal antibody anti endothelial cells CD31
(Dako, 1:30 dilution) and von Willebrand (Sigma, 1:120 dilution), and mouse monoclonal
antibody anti neutrophil elastase (Dako, 1:40 dilution).
Immunohistochemical analysis for cytokines and iNOS.
Cytokine proteins were assayed by immunohistochemical analysis according to the avidin-
biotin peroxidase method. The following primary antibodies were used: mouse monoclonal
antibodies against human INF-γ (Sigma, 1:50 dilution), IL-6 (RD System, 1:400 dilution),
TNF-α (Santa Cruz Biotechnology, 1:50 dilution) and against iNOS (Transduction
Laboratory, 1:50 dilution).
Quantitative analysis was performed using Zeiss Image software. The entire stained
biopsied sample was scanned using Adobe Photoshop software (Adobe Systems) and a
Leaf Microlumina digital camera. Collagen staining was expressed as the percentage of
the picrosirius-red stained area to the total area of the segment. The number of DR
positive (DR+) inflammatory (lymphocytes and macrophages) and endotelial cells was
expressed as cells/mm2.
Reverse transcriptase-polymerase chain reaction (RT-PCR) quantification of TNF-α,
IL-6, INF-γ, IL-1β and iNOS mRNA levels
Total mRNA was isolated from homogenized frozen samples using TRIzol reagent (BRL-
Life Technologies), as outlined by the manufacturer, and reverse transcribed using oligo
dT-20. Levels of TNF-α, IL-6, INF-γ, IL-1β and iNOS gene expression were quantified by
RT-PCR as previously described (1). To ensure that different amounts of RT-PCR
products on myocardial biopsies were not due to different starting concentrations of
mRNA, RT-PCR analysis was performed for the internal control glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA on serial 2-fold dilutions of cDNA for each
sample. The last dilution giving a positive reaction for GAPDH was used to equalize the
amount of cDNA used in each RT-PCR. The sequences of the primers used and RT-PCR
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3conditions are showed in Table 1. All primers were purchased from Pharmacia. The RT-
PCR products were electrophoresed in a 2% agarose gel and visualized with ethidium
bromide by UV light transillumination. Band density was analysed using a computerized
image densitometer (Qwin, Leica) and the expression level for each target gene was
calculated as the ratio of the density of the target gene band versus that of the GAPDH
band (densitometric ratio [mRNA for TNF-α, IL-6, INF-γ, IL-1β and iNOS / mRNA for
GAPDH].
 The variability of the reverse transcritpase-polymerase chain reaction (RT-PCR) analysis
was assayed by measuring band densities obtained for each target gene for 5 samples
assayed five times in the same amplification and again in four different amplifications. The
intra-assay and inter-assay variation coefficients were 4.1±1.2% and 4.8±1.4%,
respectively.
Localization of TNF-α, IL-6, INF-γ and iNOS mRNAs in the myocardium by in situ
hybridization
The in situ hybridization procedure was performed using complementary cDNA
photobiotin labelled probes for GAPDH (pHcGAP, ATCC n.57090), TNF-α (pE4, ATCC
n.39894), IL-6 (PT7T3D, ATCC n.3127523), INF-γ (p52, ATCC n.65948) and iNOS (ATCC
n.1351820) purchased by Vector Laboratories as previously described in details (1). The
biotinilated probe was mixed in 60 µL hybridization buffer, applied to each section, and
hybridizations were performed at 55°C overnight in humidified chamber. Washes included
stringent wash in 1x SSC for 30 minutes and 0.1x SSC for 1 hour at 55°C. The
streptavidin-biotinylated horseradish peroxidase complex in buffered sodium chloride was
used as detection reagent and 3-amino-9 ethyl-carbazole (AEC, Sigma) as cromogenic
substrate for 5 min at room temperature. The cells nuclei were counterstained with
hematoxylin (Mayer's haemalum).
Negative controls were performed by testing the sections with hybridization mixture 1)
without the probe, 2) after incubation with RNAase A (0.05 mg/mL = 4.7 Kunitz units/mL)
for 1 hour at 37°C, and 3) with application of inappropriate probe (plasmid vector
pBR322). Positive controls were obtained for each sample using a cDNA probe for the
constitutively expressed gene for GAPDH to ensure that mRNA in myocardial biopsies
was intact.
Each stained histological section was examined under a microscope (DMRB, Leica)
connected to a computerized image-analysis system (Qwin,Leica) at 400X magnifications.
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4Legend of Figure 1 of the online supplementary data
Figure 1. In situ hybridization for TNF- α (A,B), IL-6 (C,D), IFN-γ (E,F) and iNOS (G,H) in
myocardial biopsies from potentially ischemic (A,C,E,G) and non-ischemic areas (B,D,F,H)
of the same UA patients. Cytokine and iNOS genes were mainly expressed on endothelial
cells and more weakly on interstitial cells, without differences between potentially ischemic
and non-ischemic areas. Cardiomyocytes never express mRNA either for cytokines or
iNOS. (magnification x400).
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Online data supplements
Table 1 .Primer sequences and  PCR conditions
___________________________________________________________________________________________________________________________________
Target Primer sequence Product  Annealing Cycles
size temperature (°C) (n)
___________________________________________________________________________________________________________________________________
GAPDH
Forward  5’-TGAAGGTCGGAGTCAACGGATTTGGT-3’ 983pb 63 32
    Reverse   5’-CATGTGGGCCATGAGGTCCACCAC-3’
TNF α (2)
Forward 5’-GCCTGTAGCCCATGTTGTAG-3’ 438bp 57 30
Reverse 5’-AATGATCCCAAAGTAGACCTGCCC-3’
              IL6 (3)
Forward  5’-ATGAACTCCTTCTCCACAAGCGC-3’ 628bp 65 32
  Reverse    5’-GAAGAGCCCTCAGGCTGGACTG-3’
INF γ (4)
Forward 5’-GGACCCATATGTAAAAGAAGCAGA-3’ 121bp 55 35
Reverse 5’-TGTCACTCTCCTCTTTCCAATTCT-3’
IL-1β (5)
Forward 5’-AGTACCTGAGCTCGGCAGTGAA-3’ 391bp 55 35
Reverse 5’-TACGATCACTGAACTGCAGCC-3’
INOS (2)
Forward 5’-CGGTGCTGTATTTCCTTACGAGGCGAAGAAGG-3’ 391bp 62 35
Reverse 5’-GGTGCTACTTGTTAGGAGGTAAGTAAAGGGC-3’
            MCP-1 (6)
            Forward      5’-TTGTGTGCCTGCTGCTCATA-3’              259bp                  55        35
Reverse        5’- GGTTTGCTTGTCCAGGTGGT-3’
___________________________________________________________________________________________________________________
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